International Organising Committee

Symposium Chairman

Dr P. JONES (University of Dundee, Glasgow, United Kingdom)

Members

	Prof. M. ANDERLUH (University of Ljubljana, Ljubljana, Slovenia)
	Prof. K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium)
	K. BRINER (Novartis, South San Francisco, United States)
	Prof. R. DEPREZ-POULAIN (University of Lille, Lille, France)
	Prof. M. P. GOYA LAZA (Instituto de Quimica Medic, CSIC, Madrid, Spain)
	Dr A. GRAVEN SAMS (H. Lundbeck, Valby, Denmark)
	Prof. R. MOREIRA (University of Lisbon, Lisbon, Portugal)
	Dr M. TOZER (Consultant, Bognor Regis, United Kingdom)
	Dr F. VON NUSSBAUM (Bayer Pharma, Berlin, Germany)

Local Organising Committee

Chairman

Dr M. TOZER (Consultant, Bognor Regis, United Kingdom)

Members

	Dr S. BAGAL (AstraZeneca, Cambridge, United Kingdom)
	Prof. S. CONWAY (University of Oxford, Oxford, United Kingdom)
	Dr P. JONES (University of Dundee, Glasgow, United Kingdom)
	Dr A. JORDAN (Cancer Research UK Manchester Institute, Manchester, United Kingdom)
	Dr A. J. RATCLIFFE (Redx Anti-infectives Ltd, Alderley Edge, United Kingdom)
	Prof. M. WARING (Newcastle University, Newcastle upon Tyne, United Kingdom)
	Dr D. WITTY (Convergence Pharmaceuticals, United Kingdom)

International Scientific Committee

Members

	Prof. M. AMBLARD (CNRS-Universty of Montpellier I, Montpellier, France)
	Prof. A. BECK-SICKINGER (Leipzig University, Leipzig, Germany)
	Dr C. BOSS (Actelion Pharmaceuticals Ltd, Allschwil, Switzerland)
	Dr A. BROWN (Stratified Medical, Deal, United Kingdom)
	Dr J. BURROWS (Medicines for Malaria Venture (MMV), Geneva, Switzerland)
	Dr T. CALOGEROPOULOU (National Hellenic Research Foundation, Athens, Greece)
	Dr N. CARRUTHERS (Johnson & Johnson R&D, San Diego, United States)
	Dr B. CEZANNE (Merck, Darmstadt, Germany)
	Prof. K. CHIBALE (University of Cape Town, Cape Town, South Africa)
	Dr M. COGHLAN (Eli Lilly and Company, Indianapolis, Indiana, United States)
	Prof. G. COSTANTINO (University of Parma, Parma, Italy)
	Prof. B. COX (University of Sussex, Brighton, United Kingdom)
	Dr W. CZECHTIZKY (Sanofi, Mölndal, Sweden)
	Dr H. DOLLINGER (Boehringer Ingelheim Pharma, Biberach, Germany)
	Dr G. G. FERENCZY (Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary)
	Prof. B. FISCHER (Bar-Ilan University, Ramat-Gan, Israel)
	Prof. S. GOBEC (University of Ljubljana, Ljubljana, Slovenia)
	Dr E. GOMEZ (ALMIRALL, BARCELONA, Spain)
	Dr S. HADIDA (Vertex Pharmaceuticals, San Diego, United States)
	Dr A. HALL (UCB Pharma S.A., Braine-l'Alleud, Belgium)
	Prof. L. HEITMAN (University of Leiden, Leiden, The Netherlands)
	Prof. K. JOZWIAK (Medical University of Lublin, Lublin, Poland)
	Prof. I. KALVINS (Latvian Institute of Organic Synthesis, Riga, Latvia)
	Prof. A. KARLÉN (Uppsala University, Uppsala, Sweden)
	Prof. S. KNAPP (Oxford University, Oxford, United Kingdom)
	Dr S. KOSTRUN (Fidelta Ltd, Zagreb, Croatia)
	Dr M. LEMURELL (AstraZeneca, Gothenburg, Sweden)
	Prof. A. MARTINEZ (Instituto de Quimica Medica-CSIC, Madrid, Spain)
	Prof. N. MAULIDE (University of Vienna, Vienna, Austria)
	Dr L. MEERPOEL (Janssen R&D, Belgium)
	Dr C. MENET (Confo Therapeutics, Brussels, Belgium)
	Prof. A. MESSEGUER (IQAC-CSIC, Barcelona, Spain)
	Dr P. MOLENVELD (Mercachem-Syncom, Nijmegen, The Netherlands)
	Prof. C. MONTANARI (University of Sao Paulo, Sao Paulo, Brazil)
	Dr V. MOREIRA (Faculty of Pharmacy, University of Helsinki, Helsinki, Finland)
	Dr S. F. NIELSEN (LEO Pharma, Ballerup, Denmark)
	Dr U. OBST-SANDER (F.Hoffmann - La Roche, BASEL, Switzerland)
	Prof. Z. PAN (Peking University, Shenzhen, China)
	Prof. R. PELLICCIARI (TES Pharma srl, Corciano, Italy)
	Prof. M. PINTO (Faculty of Pharmacy, University of Porto, Porto, Portugal)
	Prof. V. POROIKOV (Institute of Biomedical Chemistry, Moscow, Russia)
	Dr P. RATCLIFFE (Grünenthal, Germany)
	Dr D. REES (Astex Pharmaceuticals, Cambridge, United Kingdom)
	Dr M. ROWLEY (Merck Research Laboratories, Kriens, Switzerland)
	Prof. P. H. SEEBERGER (Max Planck Institute of Colloids and Interfaces, Berlin, Germany)
	Prof. H. U. STILZ (Novo Nordisk, Cambridge, United States)
	Prof. K. STROMGAARD (University of Copenhagen, Copenhagen, Denmark)
	Prof. H. SUGA (University of Tokyo, Tokyo, Japan)
	Prof. E. TATE (Imperial College London, London, United Kingdom)
	Prof. H. TIMMERMAN (VU University Amsterdam, Oegstgeest, The Netherlands)
	Prof. M. TODD (University of Sydney, London, United Kingdom)
	Dr A. TORRENS (Esteve Pharmaceuticals, Barcelona, Spain)
	Prof. N. J. TURNER (University of Manchester, Manchester, United Kingdom)
	Dr L. VAN HIJFTE (SCT & NovAliX, Nijmegen, The Netherlands)
	Dr M. VARASI (European Institute of Oncology, Milano, Italy)
	Dr J. VELCICKY (Novartis Institutes for Biomedical Research, Basel, Switzerland)
	Dr V. . VELJKOVIC (Vinča Institute of Nuclear Sciences, Belgrade, Serbia)
	Dr M.-Q. ZHANG (Amgen China, Shanghai, China)